Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1

被引:278
作者
Huang, BH
Laban, M
Leung, CHW
Lee, L
Lee, CK
Salto-Tellez, M
Raju, GC
Hooi, SC
机构
[1] Natl Univ Singapore, Fac Med, Dept Physiol, Singapore 117597, Singapore
[2] Natl Univ Singapore, Fac Med, Dept Pathol, Singapore 117597, Singapore
基金
英国医学研究理事会;
关键词
histone deacetylase; p21(Cip1/WAF1); differentiation; tumorigenesis; cancer marker; apoptosis;
D O I
10.1038/sj.cdd.4401567
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Histone deacetylases ( HDACs) 1 and 2 share a high degree of homology and coexist within the same protein complexes. Despite their close association, each possesses unique functions. We show that the upregulation of HDAC2 in colorectal cancer occurred early at the polyp stage, was more robust and occurred more frequently than HDAC1. Similarly, while the expression of HDACs1 and 2 were increased in cervical dysplasia and invasive carcinoma, HDAC2 expression showed a clear demarcation of high-intensity staining at the transition region of dysplasia compared to HDAC1. Upon HDAC2 knockdown, cells displayed an increased number of cellular extensions reminiscent of cell differentiation. There was also an increase in apoptosis, associated with increased p21(Cip1/WAF1) expression that was independent of p53. These results suggest that HDACs, especially HDAC2, are important enzymes involved in the early events of carcinogenesis, making them candidate markers for tumor progression and targets for cancer therapy.
引用
收藏
页码:395 / 404
页数:10
相关论文
共 59 条
[31]   p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents [J].
Mahyar-Roemer, M ;
Roemer, K .
ONCOGENE, 2001, 20 (26) :3387-3398
[32]   Histone deacetylases and cancer: Causes and therapies [J].
Marks, PA ;
Rifkind, RA ;
Richon, VM ;
Breslow, R ;
Miller, T ;
Kelly, WK .
NATURE REVIEWS CANCER, 2001, 1 (03) :194-202
[33]   Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells [J].
Marks, PA ;
Richon, VM ;
Rifkind, RA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (15) :1210-1216
[34]   Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a [J].
Murphy, M ;
Ahn, J ;
Walker, KK ;
Hoffman, WH ;
Evans, RM ;
Levine, AJ ;
George, DL .
GENES & DEVELOPMENT, 1999, 13 (19) :2490-2501
[35]   P300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription [J].
Puri, PL ;
Avantaggiati, ML ;
Balsano, C ;
Sang, NL ;
Graessmann, A ;
Giordano, A ;
Levrero, M .
EMBO JOURNAL, 1997, 16 (02) :369-383
[36]   Differential roles of p300 and PCAF acetyltransferases in muscle differentiation [J].
Puri, PL ;
Sartorelli, V ;
Yang, XJ ;
Hamamori, Y ;
Ogryzko, VV ;
Howard, BH ;
Kedes, L ;
Wang, JYJ ;
Graessmann, A ;
Nakatani, Y ;
Levrero, M .
MOLECULAR CELL, 1997, 1 (01) :35-45
[37]   The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species [J].
Ruefli, AA ;
Ausserlechner, MJ ;
Bernhard, D ;
Sutton, VR ;
Tainton, KM ;
Kofler, R ;
Smyth, MJ ;
Johnstone, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (19) :10833-10838
[38]  
Sander LW, 2000, INF MENTAL HLTH J, V21, P5, DOI 10.1002/(SICI)1097-0355(200001/04)21:1/2<5::AID-IMHJ2>3.0.CO
[39]  
2-S
[40]   Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21 [J].
Shibata, MA ;
Yoshidome, K ;
Shibata, E ;
Jorcyk, CL ;
Green, JE .
CANCER GENE THERAPY, 2001, 8 (01) :23-35